Review of India's Covaxin shot underway, WHO says
Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against Covid-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
"If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a UN press briefing.
Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval.
Keep updated, follow The Business Standard's Google news channel
